Keros Therapeutics Inc (KROS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 87,014 | 110,475 | 117,755 | 148,451 | -187,353 |
| Depreciation Amortization | 1,509 | 1,109 | 714 | 344 | 1,229 |
| Accounts receivable | -825 | -750 | -13,074 | -14,549 | -2,599 |
| Accounts payable and accrued liabilities | -3,001 | -2,304 | 651 | 2,019 | -249 |
| Other Working Capital | -12,111 | 48 | -5,491 | 2,929 | -11,437 |
| Other Operating Activity | 34,919 | 26,219 | 30,993 | 21,977 | 39,540 |
| Operating Cash Flow | $107,505 | $134,797 | $131,548 | $161,171 | $-160,869 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,551 | -1,417 | -1,285 | -565 | -1,931 |
| Investing Cash Flow | $-1,551 | $-1,417 | $-1,285 | $-565 | $-1,931 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 288 | 161 | 21 | 4 | 392,275 |
| Common Stock Repurchased | -375,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -3,758 | 0 | 0 | 0 | -454 |
| Financing Cash Flow | $-378,470 | $161 | $21 | $4 | $391,821 |
| Beginning Cash Position | 561,380 | 561,380 | 561,380 | 561,380 | 332,359 |
| End Cash Position | 288,864 | 694,921 | 691,664 | 721,990 | 561,380 |
| Net Cash Flow | $-272,516 | $133,541 | $130,284 | $160,610 | $229,021 |
| Free Cash Flow | |||||
| Operating Cash Flow | 107,505 | 134,797 | 131,548 | 161,171 | -160,869 |
| Capital Expenditure | -1,551 | -1,417 | -1,285 | -565 | -1,931 |
| Free Cash Flow | 105,954 | 133,380 | 130,263 | 160,606 | -162,800 |